FI951979A0 - Konjugatvacciner mot Streptococcus av grupp B - Google Patents

Konjugatvacciner mot Streptococcus av grupp B

Info

Publication number
FI951979A0
FI951979A0 FI951979A FI951979A FI951979A0 FI 951979 A0 FI951979 A0 FI 951979A0 FI 951979 A FI951979 A FI 951979A FI 951979 A FI951979 A FI 951979A FI 951979 A0 FI951979 A0 FI 951979A0
Authority
FI
Finland
Prior art keywords
streptococcus
group
conjugate vaccines
vaccines
conjugate
Prior art date
Application number
FI951979A
Other languages
English (en)
Finnish (fi)
Other versions
FI951979A (sv
Inventor
James L Michel
Dennis L Kasper
Frederick M Ausubel
Lawrence C Madoff
Original Assignee
Gen Hospital Corp
Brigham & Womens Hospital
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Gen Hospital Corp, Brigham & Womens Hospital filed Critical Gen Hospital Corp
Publication of FI951979A0 publication Critical patent/FI951979A0/sv
Publication of FI951979A publication Critical patent/FI951979A/sv

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/315—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Streptococcus (G), e.g. Enterococci
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/09—Lactobacillales, e.g. aerococcus, enterococcus, lactobacillus, lactococcus, streptococcus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/62—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being a protein, peptide or polyamino acid
    • A61K47/64—Drug-peptide, drug-protein or drug-polyamino acid conjugates, i.e. the modifying agent being a peptide, protein or polyamino acid which is covalently bonded or complexed to a therapeutically active agent
    • A61K47/646—Drug-peptide, drug-protein or drug-polyamino acid conjugates, i.e. the modifying agent being a peptide, protein or polyamino acid which is covalently bonded or complexed to a therapeutically active agent the entire peptide or protein drug conjugate elicits an immune response, e.g. conjugate vaccines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/70—Vectors or expression systems specially adapted for E. coli
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/60—Medicinal preparations containing antigens or antibodies characteristics by the carrier linked to the antigen
    • A61K2039/6031—Proteins
    • A61K2039/6068—Other bacterial proteins, e.g. OMP

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biomedical Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Biotechnology (AREA)
  • Biophysics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Biochemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Microbiology (AREA)
  • Immunology (AREA)
  • Plant Pathology (AREA)
  • Physics & Mathematics (AREA)
  • Epidemiology (AREA)
  • Virology (AREA)
  • Communicable Diseases (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Mycology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
FI951979A 1992-11-02 1995-04-26 Konjugatvacciner mot Streptococcus av grupp B FI951979A (sv)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US96886692A 1992-11-02 1992-11-02
PCT/US1993/010506 WO1994010317A2 (en) 1992-11-02 1993-11-02 Conjugate vaccine against group b streptococcus

Publications (2)

Publication Number Publication Date
FI951979A0 true FI951979A0 (sv) 1995-04-26
FI951979A FI951979A (sv) 1995-06-29

Family

ID=25514876

Family Applications (1)

Application Number Title Priority Date Filing Date
FI951979A FI951979A (sv) 1992-11-02 1995-04-26 Konjugatvacciner mot Streptococcus av grupp B

Country Status (14)

Country Link
EP (1) EP0669985A1 (sv)
JP (1) JPH08505282A (sv)
KR (1) KR100349331B1 (sv)
AU (1) AU689452B2 (sv)
CA (1) CA2146926A1 (sv)
FI (1) FI951979A (sv)
HU (1) HU220198B (sv)
IL (1) IL107458A0 (sv)
NO (1) NO951629L (sv)
NZ (1) NZ258684A (sv)
PL (1) PL177302B1 (sv)
RU (1) RU2209247C2 (sv)
WO (1) WO1994010317A2 (sv)
ZA (1) ZA938171B (sv)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6015889A (en) * 1993-03-19 2000-01-18 Gunnar Lindahl Protein rib, a cell surface protein that confers immunity to many strains of the group B streptococcus: process for purification of the protein, reagent kit and pharmaceutical composition
US6284884B1 (en) 1995-06-07 2001-09-04 North American Vaccine, Inc. Antigenic group B streptococcus type II and type III polysaccharide fragments having a 2,5-anhydro-D-mannose terminal structure and conjugate vaccine thereof
US6426074B1 (en) * 1997-03-19 2002-07-30 The Brigham And Women's Hospital Inc. Group B Streptococcus vaccine
US7098182B2 (en) 1998-07-27 2006-08-29 Microbial Technics Limited Nucleic acids and proteins from group B streptococcus
CA2337102A1 (en) * 1998-07-27 2000-02-10 Richard William Falla Le Page Nucleic acids and proteins from group b streptococcus
EA009885B1 (ru) * 1998-12-22 2008-04-28 Майкросайенс Лимитед Применение пептидов бактерий streptococcus группы b, кодирующего их полинуклеотида, вакцина и антитело
US6890539B2 (en) 1998-12-22 2005-05-10 Microscience, Ltd. Genes and proteins, and their use
GB9910375D0 (en) * 1999-05-05 1999-06-30 Lindahl Gunnar Vaccine composition
JP4102186B2 (ja) * 2000-10-13 2008-06-18 アイディー バイオメディカル コーポレイション グループｂストレプトコッカスのｂｖｈ−ａ２及びｂｖｈ−ａ３抗原
JP5102487B2 (ja) 2003-03-07 2012-12-19 ワイス・ホールディングズ・コーポレイション 院内感染に対する免疫化のための多糖ブドウ球菌表面付着因子キャリアタンパク質接合体
PT2144924T (pt) * 2007-04-16 2016-08-17 Minervax Aps Vacina de proteína de fusão
KR101734585B1 (ko) 2008-08-28 2017-05-11 노파르티스 아게 정지 코돈 번역초과에 의한 폴리펩티드 이소형의 세포 표면 표시
WO2017068112A1 (en) 2015-10-21 2017-04-27 Minervax Aps Immunogenic fusion protein
CA3004631A1 (en) 2015-12-30 2017-07-06 Minervax Aps Immunogenic complex for eliciting protective immunity against group b streptococcus
WO2018229708A1 (en) 2017-06-16 2018-12-20 Glaxosmithkline Biologicals Sa Method of treatment
EP4061412A1 (en) 2019-11-22 2022-09-28 GlaxoSmithKline Biologicals S.A. Dosage and administration of a bacterial saccharide glycoconjugate vaccine
EP4066854A1 (en) 2021-03-29 2022-10-05 MinervaX Immunogenic fusion protein

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1987006267A1 (en) * 1986-04-16 1987-10-22 The Brigham And Women's Hospital, Inc. Bacterial antigens, antibodies, vaccines, and methods of manufacture
IL95578A (en) * 1989-09-15 1998-08-16 Gen Hospital Corp A vaccine made from polysaccharide and protein

Also Published As

Publication number Publication date
EP0669985A1 (en) 1995-09-06
JPH08505282A (ja) 1996-06-11
RU2209247C2 (ru) 2003-07-27
HU220198B (hu) 2001-11-28
CA2146926A1 (en) 1994-05-11
AU5665494A (en) 1994-05-24
PL308555A1 (en) 1995-08-21
WO1994010317A2 (en) 1994-05-11
AU689452B2 (en) 1998-04-02
HUT70981A (en) 1995-11-28
WO1994010317A3 (en) 1994-07-07
FI951979A (sv) 1995-06-29
NO951629D0 (no) 1995-04-28
KR950704492A (ko) 1995-11-20
NZ258684A (en) 1997-04-24
PL177302B1 (pl) 1999-10-29
NO951629L (no) 1995-07-03
IL107458A0 (en) 1994-02-27
KR100349331B1 (ko) 2003-01-06
ZA938171B (en) 1995-03-07

Similar Documents

Publication Publication Date Title
NO942867L (no) Syntetisk haemophilus influenzae konjugat-vaksine
DE69126606D1 (de) Vakzine
ATE161417T1 (de) Haarfrisurshampo0
BR9200337A (pt) Conjunto de par termico
NO921364D0 (no) Hybridpolypeptid
FI951979A0 (sv) Konjugatvacciner mot Streptococcus av grupp B
DE69305539T2 (de) Kopfstütze
FI944052A0 (sv) Oralt vaccin
ZA937034B (en) Group B streptococcus type II and type V polysaccharide-protein conjugate vaccines
EP0468714A3 (en) Peptide-polysaccharide-protein conjugate vaccines
DE69630611D1 (de) Antigenische präparationen
DE69331266D1 (de) Oligonucleotid-polyamide konjugate
NO943251D0 (no) Oral vaksine
AU5626998A (en) Conjugate vaccine against group B Streptococcus
FI935130A0 (fi) Raelsbund vagn med skjuttak, saerskilt foer biltransport
ATA240392A (de) Möbelgruppe
DE69326536T2 (de) Antitumor Impfstoff
KR930000941U (ko) 볼트레스 호차
ID1028B (id) Vaksin
DK59092D0 (da) Praeparat
NO923242D0 (no) Oral vaksine
NO920160D0 (no) Cytokin- og hormonbaerere for konjugatvaksiner
SE9602149D0 (sv) Conjugate vaccine against streptococcus pneumoniae
LV10395A (lv) Bezsapju vakcinas sastavs
IT223861Z2 (it) Dispositivo trasformazione lettini

Legal Events

Date Code Title Description
FD Application lapsed